Efficacy and safety of docosahexaenoic acid + eicosapentaenoic acid therapy in patients with successful coronary intervention (ESSENCE Study)
Not Applicable
- Conditions
- Hypertriglyceridaemia
- Registration Number
- JPRN-UMIN000018056
- Lead Sponsor
- Department of Cardiology, Fukuoka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Severe cardiac failure 2.Severe liver dysfunction 3.Severe renal dysfunction 4.Pregnancy or lactation in women 5.Patients with a history of allergy to any component of the study medications 6.Ineligible patients according to the judgment by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in triglyceride levels in blood.
- Secondary Outcome Measures
Name Time Method Changes in pulse wave velocity. Changes in biochemical parameters (high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol and fraction of fatty acid. Changes in triglyceride levels in blood(breakfact after 2, 4 and 8 hrs). Adverse effects. Investigate MACE (MI,TLR adnd Death) for 1 year.